The TRIB1–PPARγ Axis Regulates Cholesterol Metabolism in Pancreatic Ductal Adenocarcinoma
Annals of the New York Academy of Sciences · 2026-03 · 1557 (1)
DOI: 10.1111/nyas.70224 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the New York Academy of Sciences, online erschienen am 03.03.2026. Verfasst von Rui Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Protein Serine-Threonine Kinases, PPAR gamma, Cholesterol. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Liaoning Province Doctoral Startup Fund.
Abstract (Originalsprache)
Metabolic reprogramming, particularly the dysregulation of cholesterol metabolism, is a hallmark of pancreatic ductal adenocarcinoma (PDAC). However, the underlying molecular drivers remain largely elusive. In this study, we demonstrate that Tribbles homolog 1 (TRIB1) is elevated in PDAC tissues and is significantly associated with poor prognosis. Functionally, TRIB1 mRNA knockdown suppresses PDAC cell growth and tumor formation, while its overexpression promotes both. Mechanistically, TRIB1 protein binds to the DNA‐binding domain of PPARγ and inhibits its transcriptional activity. This interaction relieves the PPARγ‐mediated repression of HMGCR , the rate‐limiting enzyme in the mevalonate pathway, thereby fueling de novo cholesterol biosynthesis. Furthermore, in vivo experiments indicate that PDAC tumors with high TRIB1 expression were more sensitive to the HMGCR inhibitor atorvastatin. Collectively, our findings highlight the critical role of the TRIB1–PPARγ–HMGCR axis in the metabolic rewiring of PDAC and suggest that TRIB1 may serve as a predictive biomarker for optimizing statin‐based metabolic therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Dalian Medical University, Dalian, China.
- Liaoning Key Laboratory of Molecular Targeted Drugs in Hepatobiliary and Pancreatic Cancer, Dalian, China.
Förderung
- National Natural Science Foundation of China
- Liaoning Province Doctoral Startup Fund
Zitieren
APA
Sun, R., Qin, H., Zhang, W., Guo, X., Teng, Y., Xu, M., Liu, J., Ning, Z., & Wang, A. (2026). The TRIB1–PPARγ Axis Regulates Cholesterol Metabolism in Pancreatic Ductal Adenocarcinoma. Annals of the New York Academy of Sciences, 1557(1). https://doi.org/10.1111/nyas.70224
Vancouver
Sun R, Qin H, Zhang W, Guo X, Teng Y, Xu M, et al. The TRIB1–PPARγ Axis Regulates Cholesterol Metabolism in Pancreatic Ductal Adenocarcinoma. Annals of the New York Academy of Sciences. 2026;1557(1). doi:10.1111/nyas.70224
BibTeX
@article{Sun2026,
author = {Sun, Rui and Qin, Henan and Zhang, Wenhe and Guo, Xin and Teng, Yibin and Xu, Mengyuan and Liu, Jiwei and Ning, Zhen and Wang, Aman},
title = {The TRIB1–PPARγ Axis Regulates Cholesterol Metabolism in Pancreatic Ductal Adenocarcinoma},
journal = {Annals of the New York Academy of Sciences},
year = {2026},
volume = {1557},
number = {1},
doi = {10.1111/nyas.70224}
}
EUVIMED